PHATHOM PHARMACEUTICALS INC (PHAT) Stock Balance Sheet
NASDAQ:PHAT - Nasdaq - US71722W1071 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 334.68M | 381.39M | 155.40M | 183.30M | 287.50M | |||
| Receivables | 21.05M | 1.64M | N/A | N/A | N/A | |||
| Inventories | 3.11M | 1.21M | N/A | N/A | N/A | |||
| Other Current Assets | 14.98M | 13.19M | 5.10M | 3.30M | 3.90M | |||
| Total Current Assets | 373.82M | 397.43M | 160.50M | 186.50M | 291.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.49M | 3.62M | 3.50M | 2.60M | 3.40M | |||
| Other Non-Current Assets | 10.73M | 12.79M | 800.00K | 300.00K | 400.00K | |||
| Total Non-Current Assets | 13.22M | 16.41M | 4.30M | 2.90M | 3.70M | |||
| TOTAL ASSETS | 387.04M | 413.84M | 164.80M | 189.40M | 295.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 20.19M | 7.11M | N/A | 0.00 | 7.40M | |||
| Accrued Expenses | 37.96M | 19.07M | 16.20M | 13.80M | 31.40M | |||
| Accounts Payable | 7.13M | 12.60M | 10.00M | 5.20M | 16.80M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 65.29M | 38.78M | 26.20M | 18.90M | 55.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 498.12M | 437.66M | 204.80M | 89.70M | 39.60M | |||
| Other Non-Current Liabilities | 10.75M | 10.16M | 8.60M | 8.70M | 5.70M | |||
| Total Non-Current Liabilities | 508.87M | 447.82M | 213.40M | 98.40M | 45.30M | |||
| TOTAL LIABILITIES | 574.16M | 486.60M | 239.60M | 117.30M | 100.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.19B | -928.68M | -727.10M | -529.40M | -385.50M | |||
| Additional Paid In Capital | 1.00B | 855.92M | 652.30M | 601.50M | 579.80M | |||
| Common Shares | 6.00K | 5.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | 0.00 | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 68.32M | 57.95M | 41.50M | 30.50M | 28.50M | |||
| Tangible Book Value per Share | -2.74 | -1.26 | -1.80 | 2.37 | 6.82 | |||
| Total Shareholders' Equity | -187.11M | -72.76M | -74.80M | 72.20M | 194.30M | |||
| TOTAL LIABILITIES AND EQUITY | 387.04M | 413.84M | 164.80M | 189.40M | 295.10M | |||
| Statistics | ||||||||
| Debt/Equity | -2.66 | -6.02 | -2.74 | 1.24 | 0.20 | |||
| Current Ratio | 5.73 | 10.25 | 6.13 | 9.87 | 5.25 | |||
| Return On Assets (ROA) | -87.70% | -48.71% | -119.98% | -75.97% | -43.74% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -199.28% | -66.43% | |||
All data in USD , ROIC based on taxRate of 0.21